Internal Medicine · Miami, FL
NPI
1417105040
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2601 SW 37th Ave Ste 601
Miami, FL, 33133
Phone (305) 446-6414
Groups this clinician bills Medicare through
Medicare paid, 2024
$201K
3,126 services
Medicare patients, 2024
308
Average age 86
Drug cost, 2024
$710K
13,156 prescriptions
Company payments, 2023
$19
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carla Quispez-Asin was code 99348 (home e&m - new and established), 814 times for 225 patients. In total Carla Quispez-Asin billed 3,126 services in 22 codes, and Medicare paid $201K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99348 Home E&M - New and Established | Office | 814 | 225 | $57.63 | $47K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 545 | 187 | $45.49 | $25K |
| 99347 Home E&M - New and Established | Office | 534 | 195 | $36.27 | $19K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 453 | 183 | $52.17 | $24K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 158 | 158 | $137.69 | $22K |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 148 | 40 | $34.91 | $5,166 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 130 | 85 | $235.60 | $31K |
| 99349 Home E&M - New and Established | Office | 122 | 97 | $95.73 | $12K |
| 99497 Care Management/Coordination | Office | 56 | 47 | $69.98 | $3,919 |
| 99213 Office E&M - Established | Office | 34 | 18 | $64.27 | $2,185 |
| 99441 Telephone Services | Office | 31 | 30 | $46.25 | $1,434 |
| 99342 Home E&M - New and Established | Office | 29 | 29 | $61.68 | $1,789 |
| 99214 Office E&M - Established | Office | 26 | 15 | $97.79 | $2,543 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 14 | 13 | $175.37 | $2,455 |
| 99344 Home E&M - New and Established | Office | 12 | 12 | $120.48 | $1,446 |
By year: 2022 $165K for 2,342 services; 2023 $181K for 2,896 services; 2024 $201K for 3,126 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carla Quispez-Asin prescribed most often to Medicare patients was Levothyroxine Sodium, with 817 prescriptions and refills. In total Carla Quispez-Asin wrote 13,156 Medicare prescriptions that cost $710K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 817 | 912 | 99 | $9,886 |
| Atorvastatin Calcium Generic | 548 | 597 | 73 | $8,535 |
| Amlodipine Besylate Generic | 475 | 559 | 64 | $4,259 |
| Losartan Potassium Generic | 472 | 557 | 64 | $5,138 |
| Quetiapine Fumarate Generic | 451 | 451 | 60 | $6,972 |
| Memantine Hcl Generic | 361 | 372 | 46 | $27K |
| Furosemide Generic | 340 | 347 | 49 | $1,760 |
| Pantoprazole Sodium Generic | 308 | 361 | 51 | $5,193 |
| Metoprolol Succinate Generic | 288 | 305 | 45 | $5,604 |
| Donepezil Hcl Generic | 273 | 289 | 35 | $3,881 |
| Eliquis Apixaban | 273 | 273 | 39 | $164K |
| Famotidine Generic | 271 | 285 | 38 | $2,865 |
| Rosuvastatin Calcium Generic | 241 | 326 | 38 | $6,682 |
| Omeprazole Generic | 235 | 313 | 46 | $2,611 |
| Escitalopram Oxalate Generic | 232 | 246 | 41 | $3,150 |
Brand drugs: 1,308 claims; generic drugs: 11,804 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Carla Quispez-Asin $19 ($19 in general payments such as food, travel and fees) from 1 company. The largest payer was Teva Pharmaceuticals USA, Inc. with $19.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.